2007-000418-35: A double-blind, randomised, parallel group, placebo-controlled dose finding Phase II study to compare the efficacy and safety of topically applied Avugane™ of different concentrations in subjects with mild to moderate acne vulgaris |
|
|
| Completed | 2 | 48 | Europe | Avugane 0.5%, Avugane 3%, | TopoTarget A/S | Acne vulgaris of mild to moderate intensity | | 08/08 | | |
